Anti T-lymphocyte Immunoglobulin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti T-lymphocyte Immunoglobulin, covering 2023-11-28 to 2023-11-28. Get the full timeline:
Most recent: Clinical Trial Update: Anti T-lymphocyte Immunoglobulin With Post Transplant Cyclophosphamide to Prevent GVHD Post Allogeneic Transplantation [Phase 2]